Overview

A Randomised Study of Levitra to Treat Men With Erections Problems and Previously Untreated With Similar Therapy.

Status:
Completed
Trial end date:
2005-01-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to evaluate the efficacy and tolerability of the phosphodiesterase type 5 inhibitor (PDE5 inhibitor), vardenafil, in a broad population of subjects with erectile dysfunction of different aetiologies and severity, who have not been previously treated with a PDE5 inhibitor; Efficacy and safety was compared with placebo.
Phase:
Phase 4
Details
Lead Sponsor:
Bayer
Treatments:
Phosphodiesterase 5 Inhibitors
Vardenafil Dihydrochloride